TD ASSET MANAGEMENT INC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 82 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$493,000
+6.5%
21,4590.0%0.00%0.0%
Q3 2019$463,000
-6.7%
21,459
-4.9%
0.00%0.0%
Q2 2019$496,000
-2.9%
22,559
+20.9%
0.00%0.0%
Q1 2019$511,000
+23.7%
18,659
+21.5%
0.00%0.0%
Q4 2018$413,000
-2.8%
15,359
+5.5%
0.00%0.0%
Q3 2018$425,000
+16.8%
14,562
+24.9%
0.00%0.0%
Q2 2018$364,00011,6590.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TRV GP, LLC 2,981,437$86,969,00072.32%
MPM ASSET MANAGEMENT LLC 3,074,893$89,695,00060.73%
Foresite Capital Management IV, LLC 696,903$20,329,0006.66%
NEA Management Company, LLC 4,912,306$143,292,0006.18%
RA Capital Management 1,950,332$56,891,0003.04%
Trustees of Princeton University 47,643$1,390,0001.96%
Greylock XII GP LLC 54,749$1,597,0001.12%
Baker Brothers Advisors 2,708,200$78,998,0000.52%
Perceptive Advisors 664,186$19,374,0000.52%
Sofinnova Investments, Inc. 159,302$4,646,0000.41%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders